- Home
- SEER vs TNYA Comparison
SEER vs TNYA Comparison
Compare SEER & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEER
- TNYA
- Stock Information
- Founded
- SEER 2017
- TNYA 2016
- Country
- SEER United States
- TNYA United States
- Employees
- SEER N/A
- TNYA N/A
- Industry
- SEER Medicinal Chemicals and Botanical Products
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- SEER Health Care
- TNYA Health Care
- Exchange
- SEER Nasdaq
- TNYA Nasdaq
- Market Cap
- SEER 143.3M
- TNYA 138.1M
- IPO Year
- SEER 2020
- TNYA 2021
- Fundamental
- Price
- SEER $2.36
- TNYA $1.32
- Analyst Decision
- SEER Hold
- TNYA Strong Buy
- Analyst Count
- SEER 1
- TNYA 4
- Target Price
- SEER $3.00
- TNYA $17.33
- AVG Volume (30 Days)
- SEER 214.1K
- TNYA 6.8M
- Earning Date
- SEER 11-06-2024
- TNYA 11-06-2024
- Dividend Yield
- SEER N/A
- TNYA N/A
- EPS Growth
- SEER N/A
- TNYA N/A
- EPS
- SEER N/A
- TNYA N/A
- Revenue
- SEER $14,608,000.00
- TNYA N/A
- Revenue This Year
- SEER N/A
- TNYA N/A
- Revenue Next Year
- SEER $34.78
- TNYA N/A
- P/E Ratio
- SEER N/A
- TNYA N/A
- Revenue Growth
- SEER N/A
- TNYA N/A
- 52 Week Low
- SEER $1.51
- TNYA $0.99
- 52 Week High
- SEER $2.63
- TNYA $7.01
- Technical
- Relative Strength Index (RSI)
- SEER 48.61
- TNYA 30.28
- Support Level
- SEER $2.41
- TNYA $0.99
- Resistance Level
- SEER $2.52
- TNYA $3.69
- Average True Range (ATR)
- SEER 0.12
- TNYA 0.42
- MACD
- SEER -0.03
- TNYA -0.26
- Stochastic Oscillator
- SEER 15.87
- TNYA 11.02
About SEER Seer Inc.
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.